One consumer products player that insiders are loading up on here is Spectrum Brands (SPB). This company has market positions in six product categories: consumer batteries, pet supplies, electric shaving & grooming, electric personal care, portable lighting & home and garden control products. Insiders are buying this stock into strength, since shares are up a whopping 60% in 2012.
Spectrum Brands has a market cap of $2.26 billion and an enterprise value of $3.78 billion. This stock trades at a premium valuation, with a trailing price-to-earnings of 48.24 and a forward price-to-earnings of 12.26. Its estimated growth rate for this year is 52.6%, and for next year it's pegged at 2.9%. This is not a cash-rich company, since the total cash position on its balance sheet is $157.96 million and its total debt is $1.67 billion.A beneficial owner just bought 333,778 shares, or about $14.99 million worth of stock, at $44.94 per share. From a technical perspective, SPB is currently trending above its 200-day moving average and just below its 50-day moving average, which is neutral trendwise. This stock recently formed a double top at around $48.22 to $48.36 a share, and then subsequently sold off to a low of $42.19 a share. Following that selloff, shares of SPB have started to bounce off that recent low of $42.19 a share and its moving within range of triggering a near-term breakout trade. If you're bullish on SPB, then I would look for long-biased trades if this stock manages to break out back above its 50-day moving average of $45.53 a share with high volume. Look for a sustained move or close above $45.53 a share with volume that hits near or above its three-month average action of 279,390 shares. If that breakout triggers soon, then SPB will set up to re-test or possibly take out those double top resistance areas near $48.22 to $48.36 a share. Keep in mind that any move above $48.36 would then push SPB into new 52-week high territory, which is bullish technical price action. United Therapeutics Another name in the biotechnology and drugs complex that insiders are loading up on here is United Therapeutics (UTHR). This company is focused on the development and commercialization of products to address the medical needs of patients with chronic and life-threatening conditions. Insiders are buying this stock into some modest strength, since shares are up 10% in 2012.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV